Chesnara Plc: Fourth acquisition in two years
12 November 2026
Organon & Co. (NYSE: OGN) presents a unique case for investors navigating the intricate landscape of the healthcare sector. With a market capitalization of $2.06 billion,..
Investors eyeing the biotechnology sector may find Liquidia Corporation (NASDAQ: LQDA) an intriguing proposition. With its current market cap standing at $2.85 billion, Liquidia is making..
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is drawing significant attention from investors, bolstered by a robust set of buy ratings and an impressive potential upside of 43.39%...
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is making waves in the biotechnology sector with its cutting-edge approach to treating severe inflammatory, allergic, and autoimmune diseases. Despite the..
For investors with a keen eye on the biotechnology landscape, Protagonist Therapeutics, Inc. (NASDAQ: PTGX) presents a compelling opportunity. With its roots in developing innovative peptide..
Enovis Corporation (ENOV), a key player in the healthcare sector, is captivating investor attention with its potential upside of over 101%. Operating within the medical devices..
Concentra Group Holdings Parent, Inc. (NASDAQ: CON), a significant player in the U.S. healthcare sector, particularly in the medical care facilities industry, presents a compelling opportunity..
For investors keen on the healthcare sector, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) offers a compelling opportunity. Specializing in transformative medical devices, this surgical robotics company is..
For investors seeking opportunities in the healthcare sector, GoodRx Holdings, Inc. (NASDAQ: GDRX) presents an intriguing case with its significant potential upside. The company, with a..
Janux Therapeutics, Inc. (NASDAQ: JANX), a burgeoning name in the biotechnology sector, is capturing investor attention with its pioneering approach to cancer treatment through immunotherapy. With..
CG Oncology, Inc. (NASDAQ: CGON), a dynamic player in the healthcare sector, is capturing investor attention with its promising pipeline of bladder cancer therapies and an..
Bausch Health Companies Inc. (NYSE: BHC), a key player in the healthcare sector, has piqued investor interest with its diverse portfolio and substantial growth potential. Headquartered..
Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector, is steadily carving out its niche in the medical instruments and supplies industry. With..
Ardent Health, Inc. (ARDT), a prominent player in the healthcare sector specializing in medical care facilities, is capturing investor attention with its promising growth potential. Based..
For investors with an eye on the healthcare sector, Schrödinger, Inc. (NASDAQ: SDGR) presents a compelling opportunity. This New York-based company, known for its innovative use..
Travere Therapeutics, Inc. (NASDAQ: TVTX), a biopharmaceutical company headquartered in San Diego, California, is focused on developing therapies for rare kidney and metabolic diseases. With a..
For investors seeking opportunities within the biotechnology sector, Apellis Pharmaceuticals, Inc. (APLS) presents a compelling case. With a market capitalization of $2.84 billion, this Massachusetts-based company..
Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology company based in China, is making waves in the healthcare sector with its innovative pipeline targeting cancers and..
Select Medical Holdings Corporation (NYSE: SEM) operates at the intersection of healthcare innovation and patient care, providing a broad spectrum of services across critical illness recovery..
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a prominent player in the biotechnology sector, is drawing significant attention from investors with a market cap of $1.77 billion. Specializing..
